{"id":"https://openalex.org/W4362527596","doi":"https://doi.org/10.1158/1535-7163.22506652","title":"Supplemental Figure 4 from ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer\u2013Containing Antibody\u2013Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies","display_name":"Supplemental Figure 4 from ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer\u2013Containing Antibody\u2013Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362527596","doi":"https://doi.org/10.1158/1535-7163.22506652"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22506652","doi":"https://doi.org/10.1158/1535-7163.22506652","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506652","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22506652","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael J. Flynn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Flynn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039617409","display_name":"Francesca Zammarchi","orcid":"https://orcid.org/0000-0001-9457-2170","observed_orcids":["https://orcid.org/0000-0001-9457-2170"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Zammarchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036657281","display_name":"Peter C. Tyrer","orcid":"https://orcid.org/0000-0001-8004-5396","observed_orcids":["https://orcid.org/0000-0001-8004-5396"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter C. Tyrer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067431043","display_name":"Ayse U. Akarca","orcid":"https://orcid.org/0000-0003-0629-3927","observed_orcids":["https://orcid.org/0000-0003-0629-3927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ayse U. Akarca","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077270688","display_name":"Narinder Janghra","orcid":"https://orcid.org/0000-0002-2816-8281","observed_orcids":["https://orcid.org/0000-0002-2816-8281"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Narinder Janghra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054078946","display_name":"Charles E. Britten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles E. Britten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111968453","display_name":"Carin E.G. Havenith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carin E.G. Havenith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089413145","display_name":"Jean-Noel Levy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Noel Levy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047010658","display_name":"Arnaud C. Tiberghien","orcid":"https://orcid.org/0000-0002-2936-0515","observed_orcids":["https://orcid.org/0000-0002-2936-0515"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arnaud Tiberghien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044830291","display_name":"Luke A. Masterson","orcid":"https://orcid.org/0000-0002-5366-4025","observed_orcids":["https://orcid.org/0000-0002-5366-4025"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luke A. Masterson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Conor Barry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Conor Barry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014171089","display_name":"Fran\u00e7ois D\u2019Hooge","orcid":"https://orcid.org/0000-0003-2531-085X","observed_orcids":["https://orcid.org/0000-0003-2531-085X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois D'Hooge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001737873","display_name":"Teresa Marafioti","orcid":"https://orcid.org/0000-0003-1223-6275","observed_orcids":["https://orcid.org/0000-0003-1223-6275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teresa Marafioti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul W.H.I. Parren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David G. Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051368970","display_name":"Philip W. Howard","orcid":"https://orcid.org/0000-0001-6392-2289","observed_orcids":["https://orcid.org/0000-0001-6392-2289","https://orcid.org/0000-0001-7828-1154"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip W. Howard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006107477","display_name":"Patrick H. van Berkel","orcid":"https://orcid.org/0000-0002-7315-0347","observed_orcids":["https://orcid.org/0000-0002-7315-0347"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick H. van Berkel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055669649","display_name":"John Anthony Hartley","orcid":"https://orcid.org/0000-0003-3737-9897","observed_orcids":["https://orcid.org/0000-0003-3737-9897"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John A. Hartley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pyrrolobenzodiazepine-dimer","display_name":"pyrrolobenzodiazepine dimer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7950000166893005},{"id":"https://openalex.org/keywords/subcutaneous-tumor-model","display_name":"subcutaneous tumor model","score":0.7360000014305115},{"id":"https://openalex.org/keywords/in-vivo-efficacy","display_name":"in vivo efficacy","score":0.753000020980835},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.6976824998855591},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5195944309234619},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5139333605766296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.485515832901001},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4837898910045624},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40832677483558655},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36869844794273376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36554205417633057},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2642580568790436},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2628806233406067},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22148877382278442},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.21665680408477783},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18784469366073608},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.08902880549430847},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22506652","doi":"https://doi.org/10.1158/1535-7163.22506652","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506652","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22506652","doi":"https://doi.org/10.1158/1535-7163.22506652","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506652","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2479943337","https://openalex.org/W2922123088","https://openalex.org/W4392688337","https://openalex.org/W2513682949","https://openalex.org/W7165008682","https://openalex.org/W857936328","https://openalex.org/W2740746026","https://openalex.org/W2315176717","https://openalex.org/W7014724528","https://openalex.org/W7165056562"],"abstract_inverted_index":{"In":[0],"vivo":[1],"efficacy":[2],"in":[3,15],"Karpas":[4],"299":[5],"subcutaneous":[6,13],"models.":[7],"Kaplan":[8],"Meier":[9],"survival":[10],"plots":[11],"of":[12],"models":[14],"Figures":[16],"5A":[17],"and":[18],"5B":[19]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-06T00:00:00"}